HPR163 Best Practices Identified From the Analysis of 8 European Countries’ National Cancer Plans von Ktena, D, Dalakaki, E, Karokis, A, Krueger, T

Volltext

HPR76 Implementing the Recovery and Resilience Fund Initiative to Reduce Pharmaceutical Expenditure Clawback in Greece: The Impact on Pharmaceutical Spending and on National Econom... von Mylonas, C, Dalakaki, E, Skroumpelos, A, Karokis, A

Volltext

PCN70 Cost Effectiveness Analysis of Pembrolizumab in the Treatment of Adults with STAGE III Melanoma and Lymph Node Involvement WHO Have Undergone Complete Resection - the Greek S... von Yfantopoulos, N., Dalakaki, E., Papageorgiou, M., Karokis, A.

Volltext

HPR187 Assessing the Impact of Anti-PD-1/PD-L1 Inhibitors on Cancer Care Health and Budget in Greece von Ktena, D, Dalakaki, E, Dimitriadis, I, Mountain, G, Hughes, R, Clarke-Melville, S, Roediger, A, Naoum, P, Athanasakis, K

Volltext

PIN58 - Cost Minimization Analysis Of Tedizolid For The Treatment Of Acute Bacterial Skin And Skin Sub-Structure Infections (Absssi) In Greece von Insinga, R, Dalakaki, E, Retsa, MP, Karokis, A, Sarpong, EM

Volltext

Cost Minimization Analysis Of Tedizolid For The Treatment Of Acute Bacterial Skin And Skin Sub-Structure Infections (Absssi) In Greece von Insinga, R, Dalakaki, E, Retsa, MP, Karokis, A, Sarpong, EM

Volltext